Skip to main content
search

Date: Tuesday, April 28, 2026

Time: 10:00 -11:00 am ET/ 2:00 - 3:00 pm GMT

Products: SEND Explorer®

Summary

The CDISC Standard for Exchange of Nonclinical Data (SEND) has enabled the generation and exchange of structured, interoperable toxicology study datasets, providing a foundation for the development of innovative new applications of data science techniques in regulatory toxicology. One emerging application is the use of virtual control groups (VCGs), which leverage historical control data to reduce or replace the use of concurrent control animals in toxicology studies. Projects such as the IHI VICT3R initiative are using SEND-formatted toxicology study dataset repositories to develop robust matching criteria, e.g., study design, dosing regimen, and animal characteristics, to ensure appropriate VCG selection.

However, implementation of VCGs introduces significant challenges, including:

  • the need for rigorous terminology reconciliation to integrate data across studies
  • the risks of spurious selection of outlier animals
  • variability in histopathology diagnostic thresholds – an issue that may require pathologists to re-read slides to ensure accurate interpretation

Fortunately, solutions are available, ranging from tools that automate terminology reconciliation to Bayesian methods that borrow information from historical control data to improve statistical power without direct one-to-one substitution.

By addressing these challenges, SEND-driven innovations can maximize data utility, reduce redundancy, and advance the 3Rs (Replacement, Reduction, Refinement). This presentation will highlight methodologies, obstacles, and future directions for integrating SEND-enabled data science into pragmantic regulatory toxicology strategies.

Register now


Learning objectives:

  • Explain how SEND-formatted toxicology study datasets enable the implementation of virtual control groups (VCGs)
  • Identify key scientific and operational challenges in implementing VCGs
  • Compare methodological approaches for using historical controls (e.g., matched VCG selection vs. Bayesian borrowing)
  • Register now to learn how SEND-enabled virtual control groups can transform nonclinical studies, reducing animal use, strengthening science, and advancing regulatory decision-making.

Intended audience

This webinar is ideal for nonclinical and regulatory toxicologists, SEND and CDISC data specialists, biostatisticians, pathologists, and regulatory strategy professionals seeking to leverage virtual control groups and historical control data to strengthen study design, reduce animal use, and advance regulatory decision-making.

Speaker:

Kevin Snyder

Director of Nonclinical Innovation and Emerging Technologies

Register now